Food and Drug Administration

America’s drug regulator, considered the global regulatory leader; proposals to disregard Chinese clinical-trial data would hinder drug development. Has suffered high turnover including head Marty Makary’s resignation.

관련 기사

• 2026-06-20 Don’t restrict Chinese biotech